See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...
Implementation barriers remain largely programmatic, requiring integrated HIV testing, adherence support, STI services, and ...
Add Yahoo as a preferred source to see more of our stories on Google. Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or ...
Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir significantly more ...
Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...
Preexposure prophylaxis (PrEP) for HIV is a highly effective tool for preventing HIV transmission in all populations and countries. However, despite being approved and available by prescription, the ...
Daily Maverick on MSN
The long shot: Building behavioural science into HIV prevention
Lenacapavir (LEN) has arrived in South Africa, and this injectable form of pre-exposure prophylaxis (PrEP) marks a major ...
A total of 15,000 doses of injectable Lenacapavir (LEN) for use as a pre-exposure prophylaxis (PrEP) against HIV are expected ...
The HIV epidemic remains a critical public health priority in the United States. The Ending the HIV Epidemic (EHE) initiative seeks to reduce HIV diagnoses by 75% by 2025 and by 90% by 2030. Certain ...
At a pharmacy in Iowa, a 42-year-old Black gay man couldn't find a medication he needed. The pharmacist, a white woman, told him they didn't stock that medication. But while he waited to pay for his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results